DEXIS broadcasts the launch of the next-generation OP 3D. Constructed on OP 3D know-how, the OP 3D LX introduces expanded 3D diagnostic capabilities with:
- Bigger subject of view (FOV) choices now as much as 15(H) x 20(D) cm
- Seamless integration with AI-enabled DTX StudioTM Clinic software program
- Improved affected person positioning
- Enhanced picture readability
- Cloud-based service connectivity
DEXIS will probably be demonstrating the brand new OP 3D LX at sales space 956 in the course of the Pacific Dental Convention in Vancouver, CA, on March 7-9, 2024.
“The OP 3D LX presents all of the highly effective options practices know and belief from our OP 3D line, with the addition of latest improvements that present expanded flexibility, improved workflow efficiencies, and enhanced diagnostic confidence,” says Lori Clements, Vice President, Business, North America at DEXIS. “With the addition of OP 3D LX of their observe, medical doctors will be capable of improve their prognosis, planning, and therapy choices for a variety of sufferers and diagnostic wants.”
DEXIS has introduced collectively a number of the most acknowledged CBCT manufacturers within the business, together with Instrumentarium, SOREDEXTM, Cranex, GendexTM and the well-known i-CATTM. Over the past 15 years, DEXIS has labored with distributors to put in greater than 35,000 CBCT models in dental practices and continues to serve their clients with the evolving OP 3D product line.
To be taught extra concerning the new DEXIS OP 3D LX, go to www.dexis.com.
